Bloomage BioTechnology Balance Sheet Health
Financial Health criteria checks 6/6
Bloomage BioTechnology has a total shareholder equity of CN¥7.1B and total debt of CN¥40.6M, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are CN¥8.3B and CN¥1.2B respectively. Bloomage BioTechnology's EBIT is CN¥640.5M making its interest coverage ratio -28.5. It has cash and short-term investments of CN¥836.1M.
Key information
0.6%
Debt to equity ratio
CN¥40.56m
Debt
| Interest coverage ratio | -28.5x |
| Cash | CN¥836.13m |
| Equity | CN¥7.13b |
| Total liabilities | CN¥1.19b |
| Total assets | CN¥8.32b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688363's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥902.6M).
Long Term Liabilities: 688363's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥285.4M).
Debt to Equity History and Analysis
Debt Level: 688363 has more cash than its total debt.
Reducing Debt: 688363's debt to equity ratio has reduced from 2.2% to 0.6% over the past 5 years.
Debt Coverage: 688363's debt is well covered by operating cash flow (2300.2%).
Interest Coverage: 688363 earns more interest than it pays, so coverage of interest payments is not a concern.